Yet ANOTHER study finds that hydroxychloroquine did not help treat coronavirus patients

Tragedy as conspiracy theorist Max Azzarello, 37, DIES in hospital just hours after setting himself on fire while protesting outside Trump's hush money trial in New York City
Mom and four teenage girls renting an eerie Airbnb in rural Kentucky reveal why they left early after 'unsettling' discovery
Fury as US state weighs up border toll and declares war on pickup trucks in move neighboring residents insist is another 'unnecessary' money grab
AMANDA PLATELL: Just give up your royal titles Harry and become a US citizen
Megyn Kelly reveals who she voted for in 2020: 'I really wrestled with it'
Remains of extinct human species that died thousands of years ago found in kitchen floor tiles
Tucker Carlson says UFOs are piloted by 'spiritual entities' with bases 'under the ocean and the ground'
Kitty set out to have casual sex for a year to see if women really can have no-strings liaisons. What she discovered was the horrifying reality of how men now believe they can treat women in the bedroom
Florida cops arrest man for broad daylight, on-camera kidnapping of woman who was bundled into car being sold by her husband
Hell hath no fury: Texas wife shoots her husband after finding him with another woman - and then tells police 'he deserved it'
Bartender reveals the 'number one' rule customers should NEVER break when going out for drinks: 'Save yourself the embarrassment'
Man is left baffled by disastrous frosting fail on his wife's 30th birthday cake - after the baker misread their OWN writing
Woman who tried to cure her cancer with holistic diet drink almost died after she refused chemotherapy - with ex-model, 39, now saying 'you'll need something harder than carrot juice' to overcome tumours
David Beckham sues Mark Wahlberg after soccer legend claimed he was left $10.5 MILLION out of pocket from deal to act as an ambassador for the movie star's F45 fitness brand
Former Boston Red Sox star and World Series winner Dave McCarty dies aged 54 after 'cardiac event' in California
Brian McKnight slammed for calling his biological children 'evil' and 'products of sin' after praising his stepdaughter... amid bitter family feud
REVEALED: The haunting final words of researcher who set himself on fire outside Trump trial - ranted about Peter Thiel, Bill Clinton and crypto before torching himself in front of courthouse
Chilling images show conspiracy theorist stalking Trump's trial with protest signs day before setting himself on fire outside NYC court
REVEALED: Protestor's unhinged posts about Taylor Swift before he set himself alight outside Trump's hush money trial in New York City
REVEALED: Man who set himself on fire outside Trump trial had JUST finished 180 days probation over spate of troubling incidents
'An active shooter... no a man's set fire to himself!' Horrifying moment CNN hosts watch on as protester self-immolates and describes his blazing body shaking while 'engulfed in total flames'
Morgan Wallen breaks his silence since being arrested for allegedly throwing a chair off Nashville bar roof: 'I'm not proud of my behavior'
More than 10 per cent of the world's population goes to the polls as ONE BILLION set to vote in six-week Indian election in ballot that will test the limit of Narendra Modi's political prowess
Huge blast reported at military base in Baghdad: 'One person dead' after HQ of the pro-Iranian Popular Mobilization Forces in Iraq was 'struck by airstrike', security sources claim

Researchers looked at more than 1,400 coronavirus patients in New York who were given hydroxychloroquine, azithromycin, both drugs, or neither of them
There was no difference in mortality rates between the four groups of patients
However, people who took hydroxychloroquine with azithromycin were more likely to go into cardiac arrest than those in the other three groups
It's the latest in a slew of studies suggesting that the drug offers no benefit or may pose a risk of dangerous side effects to coronavirus patients
Here’s how to help people impacted by Covid-19

By Mary Kekatos Senior Health Reporter and Natalie Rahhal Acting Us Health Editor For Dailymail.com and Associated Press

Published: 18:19 EDT, 12 May 2020 | Updated: 19:49 EDT, 12 May 2020

e-mail

403

View
comments

Once again, another study has found the anti-malaria medicine hydroxychloroquine doesn't help treat coronavirus patients.

New York researchers said patients received no benefits whether they took just the drug or paired it with the antibiotic azithromycin.

Early studies suggested that hydroxychloroquine might have antiviral and anti-inflammatory effects that could help people sickened by coronavirus.

This triggered a flurry of research, an endorsement from President Donald Trump and emergency authorization from the US Food and Drug Administration (FDA).

However, scientists have learned that the drug can led lead to serious heart problems, particularly when taken together with azithromycin.

The new study doubles down on this, with researchers finding that patients who received a combination of the drugs were more likely to go into cardiac arrest compared to those who took just one of the mediations or neither of them,

A new study from researchers in New York o found there was no difference in mortality rates between patients who took hydroxychloroquine (pictured), azithromycin, both drugs or neither of them.

President Donald Trump has touted the drug as a 'game-changer' but new research suggests the drug offers no benefit or may pose a risk of dangerous side effects to coronavirus patients. Pictured: Tump speaks during a press briefing on testing in the Rose Garden, May 11

For the study, published in the Journal of the American Medical Association, the team looked at 1,438 COVID-19 patients across 25 hospitals in New York.

The study was observational, rather than an experiment comparing those treated with the drug to those who got a placebo, which is the gold-standard of trials.

Patients were either treated with hydroxychloroquine, azithromycin, both of the drugs, or neither of them.

Those taking the drugs were more likely to have diabetes, low oxygen levels and trouble breathing.

About 25 percent of patients receiving hydroxychloroquine and azithromycin died compared to around 20 percent for those who received hydroxychloroquine alone and 10 percent of those who just took azithromycin.

About 12 percent of patients that took neither drug died.

'Treatment with hydroxychloroquine, azithromycin, or both, compared with neither treatment, was not significantly associated with differences in in-hospital mortality,' the researchers wrote.

President Trump repeatedly urged the use of hydroxychloroquine, which is used now for lupus and rheumatoid arthritis.

It has potentially serious side effects, including altering the heartbeat in a way that could lead to sudden death, and the FDA has warned against its use for coronavirus infections except in formal studies.

Its warning came after Americans began hoarding the drug and several studies reported alarming rates of dangerous heart arrhythmias - a known side effect of hydroxychloroquine - in coronavirus patients treated with it.

The new research comes on the heels of another study from Columbia University, in which a team compared more than 800 patients treated with hydroxychloroquine to more than 560 who got supportive care

Of the nearly 1,400 patients in the observational study, 181 needed ventilators and 232 died, with no difference seen between the groups.

Patients given hydroxychloroquine were generally sicker than the others, but widely accepted methods were used to take that into account and still no benefit was seen for the drug.

Its use started within two days of admission for nearly all who received it. Some critics of earlier studies have said treatment may have started too late to do any good.

'It is disappointing that several months into the pandemic, we do not yet have results' from any strict tests of the drug, the authors wrote.

Still, the new study 'suggests that this treatment is not a panacea.'

The study was funded by the National Institutes of Health, which has launched two of its own trials comparing hydroxychloroquine to placebo.

One study involves COVID-19 patients, and the other aims to see whether the drug can help prevent infections in health care workers exposed to the virus. Both got started in April.

Meanwhile, remdesivir, an antiviral drug originally developed to treat Ebola, has continued to show promise for improving coronavirus patients' survival odds, earning FDA emergency use authorization and a global push to ramp up production.